Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0001472375-22-000015
Filing Date
2022-02-03
Accepted
2022-02-03 17:13:28
Documents
41
Period of Report
2021-12-31

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 1 ixform10qa.htm   iXBRL 10-Q/A 314949
2 CERTIFICATION exhibit31-1.htm EX-31.1 12880
3 CERTIFICATION exhibit31-2.htm EX-31.2 12425
4 CERTIFICATION exhibit32-1.htm EX-32.1 4536
5 CERTIFICATION exhibit32-2.htm EX-32.2 4459
6 regenerexlogo.gif GRAPHIC 5716
  Complete submission text file 0001472375-22-000015.txt   1657424

Data Files

Seq Description Document Type Size
7 SCHEMA DOCUMENT rep1357878-20211231.xsd EX-101.SCH 14579
8 CALCULATION LINKBASE DOCUMENT rep1357878-20211231_cal.xml EX-101.CAL 27283
9 DEFINITION LINKBASE DOCUMENT rep1357878-20211231_def.xml EX-101.DEF 35357
10 LABELS LINKBASE DOCUMENT rep1357878-20211231_lab.xml EX-101.LAB 125339
11 PRESENTATION LINKBASE DOCUMENT rep1357878-20211231_pre.xml EX-101.PRE 100279
35 EXTRACTED XBRL INSTANCE DOCUMENT ixform10qa_htm.xml XML 112566
Mailing Address 5348 VEGAS DRIVE #177 LAS VEGAS NV 89108
Business Address 5348 VEGAS DRIVE #177 LAS VEGAS NV 89108 (702) 805-7525
REGENEREX PHARMA, INC. (Filer) CIK: 0001357878 (see all company filings)

EIN.: 980479983 | State of Incorp.: NV | Fiscal Year End: 0331
Type: 10-Q/A | Act: 34 | File No.: 000-53230 | Film No.: 22589641
SIC: 2844 Perfumes, Cosmetics & Other Toilet Preparations